Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04737070
Other study ID # 2020PI310
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2021
Est. completion date July 1, 2021

Study information

Verified date January 2021
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigator want to study the population of high risk (over 1/50) of Trisomy 21. According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date July 1, 2021
Est. primary completion date April 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Prenatal screening of Trisomy 21 > 1/50 (high risk population) Exclusion Criteria: - No exclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Prenatal test for Trisomy 21 screening
prenatal routine test for Trisomy 21 screening (blood test + nuchal translucency test)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Outcome

Type Measure Description Time frame Safety issue
Primary number of genetics anomalies through study completion, an average of 9 months
See also
  Status Clinical Trial Phase
Completed NCT02109770 - Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
Completed NCT01925742 - Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood N/A
Completed NCT01852708 - Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
Recruiting NCT05527652 - Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia N/A
Completed NCT02278536 - Multiple Gestation Study
Completed NCT01511458 - Non-invasive Chromosomal Examination of Trisomy Study N/A
Not yet recruiting NCT05970965 - Periodontitis and Inflammation in Children With Down Syndrome/Trisomy 21: Study on Biological Samples N/A
Terminated NCT03551418 - Learning by Repetitive Viewing of Peer Modeling Patient Education Videos by Adults With Down Syndrome N/A
Completed NCT01966991 - Prenatal Screening for Down Syndrome With DNAFirst N/A
Enrolling by invitation NCT03559374 - Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)
Active, not recruiting NCT01725438 - Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells N/A
Active, not recruiting NCT05981521 - Paternal Age and Fetal Aneuploidy
Completed NCT05004337 - Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
Recruiting NCT02864108 - The Crnic Institute Human Trisome Project Biobank
Completed NCT01931644 - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Not yet recruiting NCT06200519 - Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Terminated NCT03687866 - Non-invasive Screening of Fetal Trisomy 21 by Digital PCR
Terminated NCT01545674 - Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Terminated NCT04747275 - Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients Phase 4
Completed NCT01821300 - Down Syndrome Metabolic Health Study